MENU
+Compare
RLMD
Stock ticker: NASDAQ
AS OF
Aug 7, 02:56 PM (EDT)
Price
$0.59
Change
-$0.01 (-1.67%)
Capitalization
19.88M

RLMD Relmada Therapeutics Chart, History Price & Graph

a clinical-stage biotechnology company, which engages in the development of d-methadone receptor antagonist, which is a chemical entity that addresses areas of high unmet medical need in the treatment of central nervous system diseases

RLMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RLMD showed earnings on May 12, 2025. You can read more about the earnings report here.
View a ticker or compare two or three
RLMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement

RLMD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RLMD has been loosely correlated with SYRE. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if RLMD jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLMD
1D Price
Change %
RLMD100%
+5.27%
SYRE - RLMD
36%
Loosely correlated
-5.39%
ENTO - RLMD
36%
Loosely correlated
+6.59%
PRTC - RLMD
31%
Poorly correlated
-0.10%
AVXL - RLMD
31%
Poorly correlated
+0.73%
ZVRA - RLMD
29%
Poorly correlated
+0.35%
More